Pharmacology Management of Asthma

The current concept of asthma therapy is based on a stepwise approach, depending on disease severity, and the aim is to reduce the symptoms that result from airway obstruction and inflammation, to prevent exacerbations and to maintain normal lung function. Beta adrenoceptor agonists and glucocorticoids are at present the most effective drugs for the treatment of airway obstruction and inflammation, with theophylline, leukotriene receptor antagonists and anticholinergic as second- or third-line therapy. There are, to date, no additional or newly developed drugs available that add substantially to the current strategies or even replace β2 adrenoceptor  agonists or glucocorticoids. New approaches in asthma therapy recommend drug combinations of inhaled steroids, primarily with long-acting β2 adrenoceptor agonists, based on their improved efficacy and the potential for a steroid-sparing effect.

  • Asthma
  • Asthma: Immunopathology
  • Biologics of Asthma
  • Biomarkers for Asthma & Clinical Immunology
  • Asthma and Pregnancy
  • Asthma and advanced Asthma Treatment

Related Conference of Pharmacology Management of Asthma

Pharmacology Management of Asthma Conference Speakers